scholarly journals Reduced health-care utilization among people with chronic medical conditions during coronavirus disease 2019

2020 ◽  
pp. 201010582096453
Author(s):  
Chetna Malhotra ◽  
Isha Chaudhry ◽  
Semra Ozdemir ◽  
Eric Andrew Finkelstein

The coronavirus disease 2019 (COVID-19) outbreak may impact the health-care-seeking behaviour of people with pre-existing chronic medical conditions. We aimed to assess the extent, reasons and correlates of reduced health-care utilization among people with chronic medical conditions in Singapore during the COVID-19 pandemic. We administered a web-survey to a panel of residents between 31 March and 14 April 2020. We assessed the proportion of participants with self-reported chronic conditions that missed their health-care appointment during the outbreak either voluntarily (demand driven) or because it was cancelled by their provider (supply driven). We performed a logistic regression to examine the association of voluntarily missing the health-care appointment with participants’ age and risk perceptions. Of the 1017 surveyed participants, 349 reported at least one chronic medical condition. Of these, 40% reported missing their health-care appointment during the COVID-19 outbreak. Of these, 72% did so voluntarily, and 39% reported that it was cancelled by their provider. Younger participants, those with a greater worry of contracting COVID-19 and those with a higher perceived risk of dying due to COVID-19 were more likely to miss their health-care appointments voluntarily. These results highlight the need to ensure continuity of care for people with chronic medical conditions in order to avoid the long-term impact on their health and mortality.

2020 ◽  
Vol 4 (1) ◽  
pp. e000715
Author(s):  
Amir Saeed ◽  
Eslam Shorafa ◽  
Anahita Sanaeidashti ◽  
Mohammad Rahim Kadivar

ObjectivesTo describe the clinical characteristics of paediatric patients admitted to a single paediatric intensive care unit (PICU) in Iran with COVID-19.MethodsA cross-sectional study of paediatric patients who were admitted to a COVID-19-dedicated PICU from 16 March 2020 to 21 April 2020 with COVID-19.ResultsSix children had confirmed COVID-19 and four had suspected COVID-19. Six had pre-existing chronic medical conditions. Nine had respiratory failure and needed ventilation. Five children, of whom four had chronic medical conditions, died. Four had cardiac arrhythmias. Clinical presentation included fever and cough.ConclusionCOVID-19 can be fatal in paediatric patients, especially in those with a chronic medical condition.


Medical Care ◽  
2018 ◽  
Vol 56 (8) ◽  
pp. 649-657 ◽  
Author(s):  
Kelly C. Young-Wolff ◽  
Varada Sarovar ◽  
Daniella Klebaner ◽  
Felicia Chi ◽  
Brigid McCaw

2012 ◽  
Vol 160 (2) ◽  
pp. 216-221.e1 ◽  
Author(s):  
Sara F.L. Kirk ◽  
Stefan Kuhle ◽  
Arto Ohinmaa ◽  
Ian Colman ◽  
Paul J. Veugelers

Author(s):  
Melissa M. Buttner ◽  
Michael W. O'Hara

Major depressive disorder (MDD) is a significant mental health problem with deleterious effects, including poor health related quality of life and long-term disability. Epidemiological studies suggest that women in particular are more vulnerable to an increased risk of depression, relative to men, beginning at the time of menarche through the menopausal transition. Depression comorbid with chronic medical conditions can often exacerbate the risk of depression, as well as complicate its recognition and treatment. Depression comorbidity can lead to negative outcomes, including progression of the chronic medical condition, poor treatment adherence, and mortality. In this chapter, we explore chronic medical conditions that are associated with a greater prevalence of depression in women relative to men, including type 2 diabetes, fibromyalgia, and rheumatoid arthritis. An overview of epidemiology is followed by a discussion of theories explaining depression comorbidity and approaches to recognizing and treating depression in the context of these chronic medical conditions. Finally, we discuss future research directions with the goal of informing clinical research and practice.


JAMA Surgery ◽  
2020 ◽  
Vol 155 (3) ◽  
pp. 216 ◽  
Author(s):  
Katherine C. Lee ◽  
Daniel Sturgeon ◽  
Stuart Lipsitz ◽  
Joel S. Weissman ◽  
Susan Mitchell ◽  
...  

Blood ◽  
2021 ◽  
Vol 138 (Supplement 1) ◽  
pp. 1908-1908
Author(s):  
Joyce Gyamfi ◽  
Siphra Tampubolon ◽  
Justin Tyler Lee ◽  
Farha Islam ◽  
Temitope Ojo ◽  
...  

Abstract Background: Sickle cell disease (SCD), one of the most common genetic disorders in the United States (US), affects 70,000 to 100,000 children. The burden is greatest among the African American population, where SCD impacts 1 in 365 live births. Children with SCD have been observed to have lower Health-Related Quality of life (HRQoL) due to the impact of severe disease-related complications and comorbidities, including infections, pain crises, acute chest syndrome, metabolic alterations and overt stroke. SCD and its related comorbidity and complications result in increased health care utilization, particularly emergency department use- which accounts for 80% of medical expenditure. Further, studies using US population-based data to characterize the health status and health care utilization for SCD children is lacking. With the exception of a study conducted by Boulet et al. in 2010, which examined the 1997-2005 National Health Interview Surveys (NHIS) data to describe health status and health services use among Black children aged 0-17 years with SCD. To fill this important gap, we used the 2007-2018 NHIS data to describe health status and health services use among SCD children aged 0-17 years and conducted a sub-analysis for Black children to better characterize SCD- related medical conditions affecting this population and health care utilization patterns. Methods: The study included an unweighted sample of 133,542 children, with 68,745 male children and 64,797 female children. Questionnaires were answered by a parent/guardian on behalf of the child. We examined (1) the prevalence of medical comorbidities; (2) indicators of functional status and perceived health status; (3) use of healthcare services; (4) barriers to accessing healthcare services; and (5) association of the comorbidities with the utilization of care. We hypothesized that Black children with SCD would have higher levels of disease-related complications and comorbidities, as well as healthcare utilization than their counterparts without SCD. We used logistic regression to compare the associations between 'SCD' and 'No SCD' on various medical conditions for all races and for Black children only groups. Results: Of the 133,542 children, 215 have SCD (.16%). Among the SCD children, 51.1% are male, Black: 170 (79.1%), White: 16 (7.44%), American Indian: 1(.47%), Asian 2 (.93%): other races: 21 (9.77%) and Multiple Races 5 (2.33%). Black children had a higher prevalence of SCD than other races and Black children with SCD were more likely to have a household income < 1% of the federal poverty levels compared to those without. After applying the appropriate weights to each of the demographics, children of all races with SCD had higher adjusted odds (Adjusted Odds Ratio -AOR) of having anemia (AOR 37.6; CI: 22.3, 63.3: p=0.000), respiratory allergies (AOR 2.2; CI: 1.3, 3.8; p=0.005), food/digestive allergies (AOR 2.1; CI: 1.0, 4.1: p=0.042), eczema/skin allergies (AOR 2.1; CI: 1.3, 3.6: p=0.004), and frequent severe headaches/migraines (AOR 2.2; CI: 1.1, 4.3; p=0.024). Children with SCD are also more likely to experience frequent diarrhea/colitis, although statistically non-significant. Among Black children, those with SCD had higher odds of having the following medical conditions including anemia (AOR 18.7; CI: 10.7,32.3: p=0.000), and respiratory allergies (AOR 2.4; CI: 1.3, 4.4: p=0.004) and also more likely to experience other conditions including food/digestive allergies, eczema/skin allergies, and frequent severe headaches/migraines, although statistically non-significant (p>0.5). Children of all races (26.0%) and Black children (28.8%) with SCD had at least 2 or more annual emergency room visits (p=0.000). Conclusion: Our study findings indicate that children with SCD for all races experienced significant comorbid conditions associated with disease status. Moreover, among Black children, those with SCD have increased SCD related comorbidity, worse health status, and an increased number of visits to the emergency room compared to children without SCD. This creates the urgency to address the health burden for Black children with SCD, by identifying 'beneficial' health care utilization services (non-emergency services) that improves the quality of life for SCD children. Future research should address residual gaps in information about health burden and healthcare utilization among SCD population in the US. Disclosures No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document